as 03-31-2025 12:41pm EST
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Founded: | 1968 | Country: | United States |
Employees: | N/A | City: | BEDFORD |
Market Cap: | 5.1B | IPO Year: | N/A |
Target Price: | $160.00 | AVG Volume (30 days): | 231.7K |
Analyst Decision: | Hold | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 1.77 | EPS Growth: | -12.38 |
52 Week Low/High: | $128.16 - $187.12 | Next Earning Date: | 05-06-2025 |
Revenue: | $949,245,000 | Revenue Growth: | 7.67% |
Revenue Growth (this year): | 7.24% | Revenue Growth (next year): | 7.07% |
NOVT Breaking Stock News: Dive into NOVT Ticker-Specific Updates for Smart Investing
Argus Research
6 days ago
Simply Wall St.
9 days ago
StockStory
14 days ago
Insider Monkey
21 days ago
StockStory
21 days ago
GuruFocus.com
25 days ago
Simply Wall St.
a month ago
Argus Research
a month ago
The information presented on this page, "NOVT Novanta Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.